HSBC TUR.WAR.OP.END. ICY/ DE000HS7GJK2 /
26/06/2024 15:37:37 | Chg.- | Bid15:49:00 | Ask15:49:00 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.4700EUR | - | - Bid Size: 22,300 |
- Ask Size: 22,300 |
Incyte Corporation | 62.2761 - | 31/12/2078 | Call |
GlobeNewswire
25/06
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...
GlobeNewswire
09/05
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire
08/05
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
02/04
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire
01/04
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire
28/02
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire
09/01
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
09/12/2023
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire
16/11/2023
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire
02/11/2023
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GlobeNewswire
23/10/2023
Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...
GlobeNewswire
28/08/2023
Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer
GlobeNewswire
23/03/2022
RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation An...
GlobeNewswire
14/03/2022
STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations